Utility and Feasibility of Prehospital Portable Ultrasound to Predict Heart Failure Readmission Risk
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Heart Failure
- Sponsor
- The Guthrie Clinic
- Enrollment
- 50
- Primary Endpoint
- Hospital Readmission
- Status
- Withdrawn
- Last Updated
- last year
Overview
Brief Summary
The purpose of this research is to use a handheld ultrasound to assess patients with congestive heart failure (CHF) to see if the ultrasound can help predict readmission to the hospital. The study will include patients who are admitted to the hospital for CHF. Participants will have two ultrasounds at hospital discharge and at a follow up visit.
Detailed Description
The purpose of this research is to see if a portable ultrasound can help predict readmission to the hospital for patients who are admitted to the hospital for CHF. The study will enroll patients who take part in Mobile Integrated Healthcare as part of their routine care. Participants will have two ultrasounds. The first ultrasound will be at hospital discharge. Between seven to ten days after hospital discharge participants will be visited at their home in follow-up as the usual standard of care for Mobile Integrated Healthcare. At this visit participants will have a second ultrasound. Participants will be followed for one year for hospital readmission.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Primary admission diagnosis is listed as congestive heart failure, with an acute component of decompensation.
- •Age greater than 18 years.
- •Principal residence within the geographic reach of our MIH program.
Exclusion Criteria
- •pregnant women
Outcomes
Primary Outcomes
Hospital Readmission
Time Frame: 30 days
Hospital readmission within 30 days of discharge